SEE HERE:
https://issels.com/treatment-summary/ultraviolet-blood-irradiation-therapy/
(EXCERPT)
Ultraviolet Blood Irradiation, also called Photoluminescence Therapy, is intravenously applied ultraviolet energy. Due to its profound photochemical, biochemical and physiological effects it has been of great value in a wide variety of diseases according to over 100 years of research findings.
Niels Ryberg Finsen is considered the father of Ultraviolet Blood Irradiation. In the late 1890s, he treated various skin conditions with Ultraviolet Blood Irradiation and he and his successors reported a success rate of about 98% in curing lupus vulgaris, a tuberculosis-like disease of the skin and mucous membranes. In 1903, he was awarded the Nobel Prize for his research in photochemotherapy.
In the 1930s, 1940s and 1950s, E. K. Knott, M.D. in Seattle, Washington, and other physicians applied this treatment successfully to a variety of other conditions, such as bacterial diseases, viral infections including acute and chronic hepatitis, poliomyelitis, encephalitis, overwhelming toxemias, rheumatoid arthritis and many other diseases and conditions.
In Europe, since the early 1950s, Josef M. Issels, M.D. administered Ultraviolet Blood Irradiation, or Photoluminescence Therapy, as an important component of his treatment program to thousands of his patients suffering from cancer and various immune disorders.
In IV H2O2 therapy, Hydrogen peroxide is infused into the circulatory system through a vein in the arm. It drips in over a ninety-minute period. Five cc of pharmaceutical-grade, three-percent hydrogen peroxide are put in 500 cc five percent glucose in water as a carrier solution. Two grams of magnesium chloride are added along with a small amount of manganese to prevent vein sclerosis.
In the blood, it encounters two enzymes: catalase and cytochrome-C. Catalase drives the above reaction to completion immediately. That part of the hydrogen peroxide that binds with cytochrome-C, however, is not allowed to become water and singlet oxygen for a period of forty minutes. After forty minutes of being bound to cytochrome-C this enzyme begins to act like catalase and breaks down the hydrogen peroxide to water and singlet oxygen. By this time, the hydrogen peroxide/cytochrome-C complex has been spread throughout the body. In this way the benefits of hydrogen peroxide are made available to all cells.
The effect of singlet oxygen in the human body is twofold. It kills, or severely inhibits the growth of, anaerobic organisms (bacteria and viruses that use carbon dioxide for fuel and leave oxygen as a by-product). This action is immediate, on contact with the anaerobic organism. Anaerobic bacteria are pathogens, the organisms which cause disease. All viruses are anaerobic.